4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000613
Options or other derivatives
- Chief Medical Officer acquired 69,142 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schmidt William K Chief Medical Officer | 2021-06-30 | Grant or award · Stock Option | +69,142 | 69,142 | D: show line 1 in the form |
Loading xslF345X03/edgar.xml…